RespireRx Pharmaceuticals Inc. Announces Appointment of Timothy Jones as President and Chief Executive Officer

NEXT STORY
Press release Oncology Venture secures a US $5 million (50 million SEK) equity investment from a new US based investor
PREV STORY
Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting from Relapsed / Refractory NHL and B-ALL Patients Treated at Dose Levels 1 & 2 in the Ongoing Phase 1/2a Clinical Trial of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate

author_avatar
NASDAQ Market News

Allscripts closes acquisition of McKesson’s Enterprise Information Solutions business

CHICAGO, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX), a global leader in healthcare ...

author_avatar
NASDAQ Market News

Cidara Therapeutics to Present at Two Upcoming Investor Conferences

SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a ...

author_avatar
NASDAQ Market News